Juan Antonio Blasco‐Amaro
Biographic Data
| ID | 10259309 |
|---|---|
| NAME | Juan Antonio Blasco‐Amaro |
| GIVEN NAMES | Juan Antonio |
| FAMILY NAME | Blasco‐Amaro |
| SIGNATURE | AMARO J A B |
| AFFILIATIONS | Agencia de Evaluación de Tecnologías Sanitarias |
| ORCID | 0000-0002-5500-8187 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Beyond chorea
Mutations in the NKX2-1 gene cause a group of rare diseases characterised by choreiform movements at early stages along with endocrine and respiratory abnormalities. These manifestations significantly impact patients’ daily lives and quality of life. However, the full extent of functional limitations in daily living remains poorly understood. A qualitative study, employing a focus group and 5 individual interviews, was conducted to investigate th…
Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice
Advanced therapy medicinal products (ATMPs) are a fast-growing field of medicine with wide potential application. Nevertheless, so far, only 19 have obtained European Union (EU) marketing authorisation and only 13 of these have translated successfully into clinical practice. This study conducts an umbrella review to identify the main barriers for the evaluation of ATMPs and their translation into clinical practice across the development lifecycle…
No prominent works on this page.
Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice
Advanced therapy medicinal products (ATMPs) are a fast-growing field of medicine with wide potential application. Nevertheless, so far, only 19 have obtained European Union (EU) marketing authorisation and only 13 of these have translated successfully into clinical practice. This study conducts an umbrella review to identify the main barriers for the evaluation of ATMPs and their translation into clinical practice across the development lifecycle…
Beyond chorea
Mutations in the NKX2-1 gene cause a group of rare diseases characterised by choreiform movements at early stages along with endocrine and respiratory abnormalities. These manifestations significantly impact patients’ daily lives and quality of life. However, the full extent of functional limitations in daily living remains poorly understood. A qualitative study, employing a focus group and 5 individual interviews, was conducted to investigate th…
Activities of daily living (1 work) · Authorization (1 work) · Biomedical Ethics and Regulation (1 work) · Biosimilars and Bioanalytical Methods (1 work) · Business (1 work) · Clinical Practice (1 work) · Clinical trial (1 work) · European union (1 work) · Family medicine (1 work) · Focus group (1 work)